Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
radiotherapy
Biotech
ESMO: Lantheus' radiotherapy readout not enough to best Pluvicto
Lantheus may have been hoping that “statistically significant” data for its radioligand therapy would make a splash, but not everyone is impressed.
James Waldron
Sep 16, 2024 8:55am
FDA sinks Actinium's radiotherapy blood cancer filing plans
Aug 5, 2024 8:12am
Novartis pays PeptiDream $180M as radiopharma big bang continues
Apr 30, 2024 4:12am
How Novartis is disrupting Lilly's $1.4B radiotherapy plan
Dec 5, 2023 11:21am
RefleXion nets $105M for guided radiotherapy commercial push
Nov 15, 2023 10:40am
Galera lays off 70% as radiotherapy complication drug rejected
Aug 10, 2023 8:19am